News

GlobalData on MSN22h
Japan’s MHLW approves GSK’s Blenrep combos for multiple myeloma
The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted approval for the use of GSK’s Blenrep (belantamab ...
Managed Healthcare Executive17h
Researchers Gain Insight into Eye Side Effects of Blenrep
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
The Pharma Letter22h
GSK’s Blenrep combination approved by Japan MHLW
Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved UK pharma major GSK’s (LSE: GSK) Blenrep (belantamab ...
The Pharma Letter18h
CEO among 25% of staff out the door at cash-strapped Prime
Shares in Prime Medicine, a US biotech seeking to develop one-time curative genetic therapies, closed 16% lower Monday.